FDA Inspection 1070387 — Austin Kulasekararaj, M.D.
The FDA completed an inspection of Austin Kulasekararaj, M.D. on Sep 21, 2018 in London. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 21, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- London (United Kingdom)
Additional Details
Clinical Investigator (CI)